QCM Reports on other companies10 Feb 2023 15:52
Has anyone found any other research conducted by QCM on other companies, and if so, are they similar to the "paper of guff" that some have claimed QCM have produced on Darktrace?
I've found one which seems similar in approach and tactics, except even more excoriating, predicting a share price of exactly USD 0.00. Further, QCM made a complaint to the U.S. Food and Drug Administration (FDA) and the U.S. Securities and Exchange Commission (SEC) about the company's conduct and products, but it's not clear to me whether these have been investigated, are ongoing, or rejected.
The company's share price is currently far from zero, and the company is in the process of taking legal action against QCM - and a number of other parties - for, it claims, manipulating the share price and financially benefiting from their short position and defaming the company with a campaign of disinformation, the same accusation that some here are claiming.
An extract from MarketWatch from Nov 2022 (company name removed):
. . . . . . . . . . . .
In the suit, the company claimed the short sellers had publicized that it had manipulated the testing and the results associated with the product, and the company was a fraud. The company alleged more than 240 false and defamatory comments in letters, reports and presentations, and more than 840 false and defamatory statements on social media.
One of the defendants said it might be able to turn the lawsuit against the company. "We stand behind everything we wrote," said Gabriel Grego, managing partner of Quintessential Capital Management..
"This is one of the most frivolous lawsuits I’ve ever seen, and I expect it will be quickly dismissed. If it’s not, we look forward to getting discovery on the company," Grego added.
. . . . . . . . . . . .
Interestingly, the percentage of floated shares that were shorted at end of Jan 2023 was 25.10% (twenty five point one!), according to MarketWatch today, which it seems was over 24.5% of the total shares in issue - makes the few percent of Darktrace's seem utterly inconsequential.